Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Icosavax, Inc.
  6. News
  7. Summary
    ICVX   US45114M1099

ICOSAVAX, INC.

(ICVX)
  Report
Delayed Nasdaq  -  04:00 2022-10-05 pm EDT
3.060 USD   -4.97%
10/04Icosavax : Corporate Overview
PU
10/04Icosavax Starts Early-Stage Test of Bivalent Vaccine Candidate IVX-A12 in Older Adults
MT
10/04Icosavax Initiates Phase 1 Trial of IVX-A12 Against RSV and hMPV in Older Adults
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ICOSAVAX, INC.
10/04Icosavax : Corporate Overview
PU
10/04Icosavax Starts Early-Stage Test of Bivalent Vaccine Candidate IVX-A12 in Older Adults
MT
10/04Icosavax Initiates Phase 1 Trial of IVX-A12 Against RSV and hMPV in Older Adults
AQ
08/16Sector Update: Health Care Stocks Narrowly Lower This Afternoon
MT
08/16Sector Update: Health Care
MT
08/16Icosavax : Corporate Overview
PU
08/16Icosavax Q2 Net Loss Narrows, Revenue Declines
MT
08/15Icosavax : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - F..
PU
08/15Earnings Flash (ICVX) ICOSAVAX Posts Q2 Loss $-0.57
MT
08/15Earnings Flash (ICVX) ICOSAVAX Posts Q2 Loss $-0.57
MT
08/15Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
AQ
08/15Icosavax, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
CI
07/28Icosavax : Corporate Overview
PU
07/28Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additio..
AQ
07/28Icosavax Announces Results from Ivx-411 Drug Product Investigation and Outlines Additio..
CI
More most relevant news
All news about ICOSAVAX, INC.
10/04Icosavax : Corporate Overview
PU
10/04Icosavax Starts Early-Stage Test of Bivalent Vaccine Candidate IVX-A12 in Older Adults
MT
10/04Icosavax Initiates Phase 1 Trial of IVX-A12 Against RSV and hMPV in Older Adults
AQ
08/16Sector Update: Health Care Stocks Edging Lower Near Tuesday Close
MT
08/16Sector Update: Health Care Stocks Narrowly Lower This Afternoon
MT
08/16Sector Update: Health Care
MT
08/16Icosavax : Corporate Overview
PU
08/16Icosavax Q2 Net Loss Narrows, Revenue Declines
MT
08/15ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/15Icosavax : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - F..
PU
More news
News in other languages on ICOSAVAX, INC.
08/16Mise à jour sectorielle : Les actions du secteur de la santé en ..
08/16Mise à jour sectorielle : Les actions du secteur de la santé ont..
08/16Mise à jour sectorielle : Soins de santé
08/16La perte nette d'Icosavax au 2e trimestre se réduit, les revenus diminuent
08/15Icosavax, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le ..
07/28Icosavax annonce les résultats de l'étude sur le produit pharmaceutique Ivx-411 et prés..
06/29Mise à jour sectorielle : Les actions du secteur de la santé gri..
06/28Icosavax annonce les résultats d'un essai intermédiaire pour un candidat vaccin contre ..
06/28Icosavax, Inc. annonce des résultats préliminaires positifs de la phase 1/1b pour le ca..
05/16Icosavax, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
More news
Analyst Recommendations on ICOSAVAX, INC.
06/30Evercore ISI Raises Icosavax to Outperform From In-Line, Price Target to $18 From $10
MT
03/25Evercore ISI Downgrades Icosavax to In-Line From Outperform
MT
2021Icosavax : Shares Gain After Analysts Initiate Coverage
MT
2021Icosavax : Evercore ISI Initiates Coverage on Icosavax With Outperform Rating, ..
MT
2021Icosavax : Jefferies Initiates Coverage on Icosavax With Buy Rating, $50 Price ..
MT
More recommendations
Press releases
10/04Icosavax : Corporate Overview
PU
10/04Icosavax Initiates Phase 1 Trial of IVX-A12 Against RSV and hMPV in Older Adults
AQ
08/16Icosavax : Corporate Overview
PU
08/15ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/15Icosavax : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - F..
PU
More press releases
Upcoming event on ICOSAVAX, INC.